# INTEGRATING PHARMACY-BASED PREVENTION&TREATMENT OF OPIOID&OTHER SUBSTANCE USE DISORDERS: A SURVEY OF PHARMACISTS&STAKEHOLDERS. 9/1/2020-7/31/2022. N01

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2020 · $350,016

## Abstract

Integrating pharmacy-based prevention and treatment of opioid and other substance use disorders: A survey of pharmacists and stakeholder (CTN-0105)

## Key facts

- **NIH application ID:** 10288033
- **Project number:** 75N95019D00013-0-759502000005-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** PAUL VANVELDHUISEN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $350,016
- **Award type:** —
- **Project period:** 2020-09-01 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10288033

## Citation

> US National Institutes of Health, RePORTER application 10288033, INTEGRATING PHARMACY-BASED PREVENTION&TREATMENT OF OPIOID&OTHER SUBSTANCE USE DISORDERS: A SURVEY OF PHARMACISTS&STAKEHOLDERS. 9/1/2020-7/31/2022. N01 (75N95019D00013-0-759502000005-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10288033. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*